Much like California and its lack of rain, we had an ongoing drought of therapies for melanoma for many years.
MelanomaPatient StoriesPediatric Cancer
By Jenny Valles
Leah Valles, age 12, is an inspiration every day. After her hard battle with stage III melanoma, she decided that people just don’t know that skin cancer is deadly, that it can be prevented, and that it is the fastest growing cancer among teens and young adults.
Safe from the Sun began in 2002 as a small group walking in the King of Prussia Mall to bring melanoma awareness to our community. The event quickly grew and expanded to Villanova University, with satellite events in Seattle, WA, and Phoenix, AZ.
Catherine Poole breaks down the emerging immunotherapy options for Melanoma, not to be confused with the common skin cancers (basal-cell carcinoma and squamous-cell carcinoma) largely caused by exposure to UV rays.
Cancer ResearchFamily MembersMelanoma
Diagnosed with melanoma a few weeks after her wedding, Meredith died of the disease 4 months later, at age 35. Her family created Meredith’s Mission for Melanoma, a non-profit organization, to support melanoma research and increase awareness of this deadly cancer.
By Nasreen A. Vohra, MD, FACSNasreen A. Vohra, MD, FACS, Judy B. Koutlas, RN, MS, OCNNasreen A. Vohra, MD, FACS, Judy B. Koutlas, RN, MS, OCN, Catherine M. Poole
Melanoma is a type of skin cancer that begins in the melanocytes, skin cells that give the skin its color. Melanoma is a serious cancer, but when caught early, it is highly treatable.
By Wayne Kuznar
Several immunotherapies known as immune checkpoint inhibitors are available today for patients with melanoma, as well as targeted therapies for patients with a BRAF or MEK gene mutation, but there are no effective treatments approved for patients with metastatic (spreading) or nonresectable (cannot be removed by surgery) melanoma whose disease progressed (got worse) after using an immune checkpoint inhibitor, or a BRAF or MEK inhibitor for those with gene mutations.
Results 1 - 17 of 17